Geography or pathology? Regional variation in atrial septal defect closure rates and techniques
- PMID: 21729512
- DOI: 10.1017/S1047951111000618
Geography or pathology? Regional variation in atrial septal defect closure rates and techniques
Abstract
Background: Since the introduction of percutaneous closure in the United States, rates of secundum atrial septal defect and patent foramen ovale closures have increased substantially. Whether or not closure rates are uniform or vary due to differences in regional practice patterns is unknown. We sought to investigate this by comparing regional rates of closure across Florida.
Methods: We identified all atrial septal defect closures from 2001 to 2006 in the Florida State Inpatient Database. Using small area analysis, zip codes were assigned to Hospital Referral Regions based on where patients were most likely to go for closure. We obtained population-normalised rates of overall, percutaneous, and surgical closure.
Results: Of 1830 atrial septal defect and patent foramen ovale closures from 2001 to 2006, 751 were surgical and 1004 were percutaneous. The statewide closure rate was 1.91 per 100,000 people per year; regional rates varied 3.8-fold from 0.78 to 2.94 per 100,000 people per year. Percutaneous rates varied sevenfold from 0.25 to 1.75 per 100,000 people per year, while surgical rates varied 2.71-fold from 0.53 to 1.44 per 100,000 people per year.
Conclusions: Despite a consistent prevalence of atrial septal defects, and patent foramens ovale, rates of repair vary across regions, suggesting that closure is driven by provider practice patterns rather than patient pathology. Efforts should be directed towards increasing consensus regarding the appropriate, evidence-based indications for closure so as to avoid the costs and potential negative sequelae of over- or undertreatment.
Similar articles
-
The rush to atrial septal defect closure: is the introduction of percutaneous closure driving utilization?Ann Thorac Surg. 2008 Nov;86(5):1584-90; discussion 1590-1. doi: 10.1016/j.athoracsur.2008.06.079. Ann Thorac Surg. 2008. PMID: 19049754
-
Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.Am Heart J. 2009 May;157(5):867-74. doi: 10.1016/j.ahj.2009.02.019. Am Heart J. 2009. PMID: 19376313
-
Results of the U.S. multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects.J Am Coll Cardiol. 2007 Jun 5;49(22):2215-21. doi: 10.1016/j.jacc.2006.11.053. Epub 2007 May 9. J Am Coll Cardiol. 2007. PMID: 17543643
-
[Non-surgical closure of type-II atrial-septal defect and patent foramen ovale].Schweiz Med Wochenschr. 1997 Dec 6;127(49):2054-60. Schweiz Med Wochenschr. 1997. PMID: 9476306 Review. German.
-
Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.Minerva Cardioangiol. 2009 Feb;57(1):103-15. Minerva Cardioangiol. 2009. PMID: 19202522 Review.
Cited by
-
Large regional variation in cardiac closure procedures to prevent ischemic stroke in Switzerland a population-based small area analysis.PLoS One. 2024 Jan 2;19(1):e0291299. doi: 10.1371/journal.pone.0291299. eCollection 2024. PLoS One. 2024. PMID: 38166018 Free PMC article.
-
Trends in the Prevalence of Atrial Septal Defect and Its Associated Factors among Congenital Heart Disease Patients in Vietnam.J Cardiovasc Dev Dis. 2019 Dec 27;7(1):2. doi: 10.3390/jcdd7010002. J Cardiovasc Dev Dis. 2019. PMID: 31892227 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
